137 related articles for article (PubMed ID: 11341354)
1. Investigating the role of immunomodulation for colon cancer prevention: results of an in vivo dose escalation trial of levamisole with immunologic endpoints.
Holcombe RF; Milovanovic T; Stewart RM; Brodhag TM
Cancer Detect Prev; 2001; 25(2):183-91. PubMed ID: 11341354
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation with low dose levamisole in patients with colonic polyps.
Holcombe RF; McLaren CE; Milovanovic T
Cancer Detect Prev; 2006; 30(1):94-8. PubMed ID: 16458451
[TBL] [Abstract][Full Text] [Related]
3. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
[TBL] [Abstract][Full Text] [Related]
4. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
5. Immunologic effects of levamisole in mice and humans: evidence for augmented antibody response without modulation of cellular cytotoxicity.
Tempero MA; Haga Y; Sivinski C; Birt D; Klassen L; Thiele G
J Immunother Emphasis Tumor Immunol; 1995 Jan; 17(1):47-57. PubMed ID: 7728305
[TBL] [Abstract][Full Text] [Related]
6. Immunological alterations induced by adjuvant treatment of postoperative colon carcinoma Duke's B or C with levamisole in combination with 5-FU.
De Brabander M; Vandebroek J; Wassenaar H; De Crée J; Baisier A; Demoen B; De Ridder R; Jagers E; Roels V; Vogels O
Anticancer Res; 1995; 15(5B):2271-7. PubMed ID: 8572636
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of three antibiotics on T helper cell cytokine expression.
Williams AC; Galley HF; Watt AM; Webster NR
J Antimicrob Chemother; 2005 Sep; 56(3):502-6. PubMed ID: 16006447
[TBL] [Abstract][Full Text] [Related]
8. Levamisole promotes murine bone marrow derived dendritic cell activation and drives Th1 immune response in vitro and in vivo.
Fu Y; Wang T; Xiu L; Shi X; Bian Z; Zhang Y; Ruhan A; Wang X
Int Immunopharmacol; 2016 Feb; 31():57-65. PubMed ID: 26706452
[TBL] [Abstract][Full Text] [Related]
9. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
[TBL] [Abstract][Full Text] [Related]
10. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
11. Correlation between phenotypic characteristics of mononuclear cells isolated from human periapical lesions and their in vitro production of Th1 and Th2 cytokines.
Colić M; Lukić A; Vucević D; Milosavljević P; Majstorović I; Marjanović M; Dimitrijević J
Arch Oral Biol; 2006 Dec; 51(12):1120-30. PubMed ID: 16797478
[TBL] [Abstract][Full Text] [Related]
12. The protective efficacy against Schistosoma japonicum infection by immunization with DNA vaccine and levamisole as adjuvant in mice.
Wang X; Jin H; Du X; Cai C; Yu Y; Zhao G; Su B; Huang S; Hu Y; Luo D; She R; Luo X; Zeng X; Yi X; Wang B
Vaccine; 2008 Mar; 26(15):1832-45. PubMed ID: 18329762
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection.
Barth H; Klein R; Berg PA; Wiedenmann B; Hopf U; Berg T
Hepatogastroenterology; 2003; 50(49):201-6. PubMed ID: 12630023
[TBL] [Abstract][Full Text] [Related]
15. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
16. T-helper type 1 cytokine release is enhanced by in vitro zinc supplementation due to increased natural killer cells.
Metz CH; Schröder AK; Overbeck S; Kahmann L; Plümäkers B; Rink L
Nutrition; 2007 Feb; 23(2):157-63. PubMed ID: 17150331
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect.
Shlomai A; Trop S; Gotsman I; Jurim O; Diment J; Alper R; Rabbani E; Engelhardt D; Ilan Y
J Pathol; 2001 Nov; 195(4):498-507. PubMed ID: 11745683
[TBL] [Abstract][Full Text] [Related]
18. Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer.
McNeel DG; Nguyen LD; Ellis WJ; Higano CS; Lange PH; Disis ML
Prostate; 2001 May; 47(3):222-9. PubMed ID: 11351352
[TBL] [Abstract][Full Text] [Related]
19. Induction of CD69 expression and Th1 cytokines release from human peripheral blood lymphocytes after in vitro stimulation with Alloiococcus otitidis and three middle ear pathogens.
Harimaya A; Himi T; Fujii N; Tarkkanen J; Carlson P; Ylikoski J; Mattila P
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):385-92. PubMed ID: 15708312
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
